Zymergen Inc. (ZY) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $2.43. It has a SharesGrow Score of 25/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Financials: revenue is $17M, +6.1%/yr average growth. Net income is $362M (loss), growing at -24.4%/yr. Net profit margin is -2160.8% (negative). Gross margin is -316.4% (+249.3 pp trend).
Balance sheet: total debt is $44M against $408M equity (Debt-to-Equity (D/E) ratio 0.11, conservative). Current ratio is 5.54 (strong liquidity). Debt-to-assets is 8.4%. Total assets: $522M.
Analyst outlook: 0 / 6 analysts rate ZY as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 40/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 15/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).